CCS
SQNM

Crosspoint Capital Strategies’s SEQUENOM INC NEW SQNM Stock Holding History

Crosspoint Capital Strategies’s Portfolio SQNM Stock Details SQNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-675
Closed -$2K – 691
2014
Q1 		$2K Hold
675
– – ﹤0.01% 648
2013
Q4 		$2K Buy
+675
New +$1.6K ﹤0.01% 552

Other funds holding SQNM

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PCM
Proxima Capital Management New York $21M AUM 3.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Crosspoint Capital Strategies's SQNM Position: Q2 2014 in Review

Crosspoint Capital Strategies sold out of SEQUENOM INC NEW (SQNM) in Q2 2014, closing a stake of 675 shares — an estimated $2K sold.

Crosspoint Capital Strategies first reported a position in SQNM in Q4 2013 and held it in 2 quarters. The position peaked at $2K in Q1 2014. 113 funds tracked by Wall St. Rank hold SQNM as of Q2 2014.

  • Crosspoint Capital Strategies reported no remaining SEQUENOM INC NEW position as of Q2 2014 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 675 SEQUENOM INC NEW shares in Q2 2014, an estimated $2K.
  • Crosspoint Capital Strategies first reported a position in SEQUENOM INC NEW in Q4 2013 and held it in 2 quarters.
  • Crosspoint Capital Strategies's SEQUENOM INC NEW position peaked at $2K in Q1 2014.
  • 113 funds tracked by Wall St. Rank held SEQUENOM INC NEW as of Q2 2014.

Based on Crosspoint Capital Strategies's 13F filing for Q2 2014, filed 29 Jul 2014.